The morbidity of simultaneous pancreatic and liver resection for metastatic pancreatic neuroendocrine tumors
Authors:
- 28 July 2025
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (10) , 102163
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (R37CA238435)
This publication has 23 references indexed in Scilit:
- The impact of obesity on in-hospital outcome of patients who underwent hepatic resection surgeries; a US national-wide studyHPB, 2025
- Risk factors for surgical site infections following hepatobiliary surgery: An umbrella review and meta-analysesEuropean Journal of Surgical Oncology, 2024
- The impact of obesity and severe obesity on postoperative outcomes after pancreatoduodenectomySurgery, 2021
- Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasisJournal of Surgical Oncology, 2019
- Prediction of Discharge Destination Following Major HepatectomyHPB, 2019
- Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumorsSurgery, 2018
- Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?Surgery, 2016
- Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomesCancer, 2014
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer1Journal of the American College of Surgeons, 2004